- 期刊
Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing
延伸閱讀
- Wu, H. P., Chu, C. M., Lin, C. Y., Yu, C. C., Hua, C. C., Yu, T. J., & Liu, Y. C. (2016). Liver Cirrhosis and Diabetes Mellitus Are Risk Factors for Staphylococcus aureus Infection in Patients with Healthcare-Associated or Hospital-Acquired Pneumonia. Pulmonary Medicine, 2016(), 29-34. https://doi.org/10.1155/2016/4706150
- Hector, A., Kappler, M., & Griese, M. (2010). In Vitro Inhibition of Neutrophil Elastase Activity by Inhaled Anti-Pseudomonas Antibiotics Used in Cystic Fibrosis Patients. Mediators of Inflammation, 2010(), 1114-1118. https://doi.org/10.1155/2010/809591
- Lam, J., Vaughan, S., & Parkins, M. D. (2013). Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, (2013), 61-77. https://doi.org/10.4137/CCRPM.S10592
- Pang, A. H. (2021). Mycobacterial Infections：Part I：Antibiotic Regimens and Clinical Outcomes of Mycobacterium abscessus complex Lung DiseasesPart II：Therapeutic Drug Monitoring of Rifabutin [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202104202
- 吳宜真（2008）。Analysis of prognosis factors for Pseudomonas aeruginosa bacteremia and risk factors for multidrug-resistant Pseudomonas aeruginosa bacteremia with emphasis on the effect of antimicrobial therapy〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2008.01458